• FDA, AbbVie + DJS, Roche + Hookipa, Kyverna

  • 2022/10/26
  • 再生時間: 8 分
  • ポッドキャスト

FDA, AbbVie + DJS, Roche + Hookipa, Kyverna

  • サマリー

  • Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future.

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    FDA
    AbbVie + DJS
    Roche + Hookipa
    Kyverna

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    続きを読む 一部表示

あらすじ・解説

Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
FDA
AbbVie + DJS
Roche + Hookipa
Kyverna

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

FDA, AbbVie + DJS, Roche + Hookipa, Kyvernaに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。